Navigation Links
TraceLink Files Patent Reexamination Petition on Unisone Patent with United States Patent and Trademark Office
Date:11/13/2013

Wakefield, MA (PRWEB) November 13, 2013

TraceLink Inc., the leader in global pharmaceutical track and trace and supply network towers, announced today that it has filed a reexamination petition with the United States Patent and Trademark Office relating to patent 6996538 owned by Unisone Strategic IP, Inc., a financial stakeholder in Frequentz, LLC.

On July 25, 2013, Unisone filed a complaint (case # ‘13CV1743 JAH WVG, U.S. District Court for the Southern District of California) alleging TraceLink is in violation of a patent held by Unisone concerning inventory control. This was the second lawsuit filed in 2013 by Unisone (see Unisone Strategic IP, Inc. v. Life Technologies Corporation et al. case # ‘13CV1278 GPC JMA, U.S. District Court for the Southern District of California) that according to court documents alleged infringement of a 2006 patent Unisone was granted on inventory control systems.

TraceLink filed a 665 page patent reexamination petition of the ‘538 patent on November 4, 2013 with the United States Patent and Trademark Office (see USPTO Application Number 09799879). TraceLink has asked industry participants and software technology providers to submit additional prior art. Interested parties who would like to learn more about the reexamination petition and supporting prior art may visit here or contact TraceLink for more information.

“TraceLink has worked tirelessly to develop unique, innovative software solutions that help the pharmaceutical industry protect patient safety and improve global access to safe medicines,” said Shabbir Dahod, President and CEO of TraceLink. “As shown in the court documents, we are vigorously defending the innovations of the TraceLink Life Science Cloud platform against infringement claims. Furthermore, TraceLink has filed a patent reexamination petition on the underlying Unisone patent.”

About TraceLink
TraceLink protects patients, enables health, grows profits and ensures compliance for companies across the global Life Sciences network through the TraceLink Life Sciences Cloud. The TraceLink Life Sciences Cloud is an Amazon AWS-based cloud application platform which enables complete global connectivity, visibility and traceability of pharmaceuticals from raw materials to patient. A single point and click connection to the Life Sciences Cloud delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. Winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is relied upon by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit http://www.tracelink.com or follow us on LinkedIn.

Read the full story at http://www.prweb.com/releases/tracelink-defends-pharma/unisone-patent/prweb11323910.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. TraceLink and Optel Vision Collaborate for End-to-End Pharmaceutical Serialization, ePedigree and Global Track & Trace Solution
2. TraceLink Life Sciences Cloud Wins Edison Innovation Award
3. TraceLink Leads Pharmaceutical Track and Trace, Big Data and Cloud-based Supply Networks Discussion at LogiPharma Europe Conference
4. TraceLink Life Sciences Cloud Named Edison Awards Finalist
5. TraceLink Life Sciences Cloud Named Amazon AWS Grand Prize Winner for Protecting Patients, Enabling Health, Ensuring Track and Trace Compliance
6. Emerging Drug Delivery Technologies, Profiles of Start-ups and Early-Stage Companies
7. Demas Law Group Files Claim Against Townsend and Costco in Frozen Berries Case
8. The Federal Trade Commission Files Lawsuit Seeking an Injunction Against Marketer of Weight-loss Products Over Alleged False Advertising, Parker Waichman LLP Reports
9. New with Dokmee Cloud, One's Files Will Never be Dropped or Boxed
10. New Mexico Woman Alleges Mirena IUD Perforated Her Uterus; Parker Waichman LLP Files Lawsuit
11. Marler Clark files Third Hepatitis A-Related Lawsuit Against Townsend Farms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... ... , ... Johns Hopkins All Children's Hospital celebrated a major milestone with the ... marked the halfway point of construction and lifting of the final beam on the ... a center for innovation aimed at finding new discoveries and treatments for childhood diseases. ...
(Date:2/19/2017)... (PRWEB) , ... February 19, 2017 , ... Braun Industries ... JEMS Conference & Exposition, the event will take place February 23-25, 2017 at the ... will be in Booth #909 with three new ambulances on display. ...
(Date:2/18/2017)... ... 2017 , ... Focused start-ups, not traditional health care organizations, ... the recent NEJM Catalyst Insights Report on the New Marketplace. , NEJM ... a qualified group of U.S. executives, clinical leaders, and clinicians at organizations directly ...
(Date:2/18/2017)... ... February 18, 2017 , ... A new ... and contact points to easily connect elderly veterans of America's armed forces to ... funding. It also conveys material on this year's increase in the Veterans Pension ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... brings its educational assistance management solution to the exhibit floor for the ... Orlando, Fla. , From Feb. 19–23, 2017, more than 40,000 healthcare industry ...
Breaking Medicine News(10 mins):
(Date:2/19/2017)... February 18, 2017 Marapharm (OTCQB: ... purchase a Medical Delivery Service with the specific and ... between qualified patients and caregivers. The delivery service is ... in the Coachella Valley, California . ... Angeles area to the West, population 19,000,000. ...
(Date:2/17/2017)... Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, Gynaecology, Musculoskeletal, ... to grow at a CAGR of 9.4% from 2017-2022 and CAGR ... a CAGR of 9.5% from 2017 to 2027. The market is ... ... you Read on to discover how you can exploit the ...
(Date:2/17/2017)... plc (NYSE, TASE: PRGO) today announced it has received final ... bitartrate and homatropine methylbromide oral solution (syrup), 5 mg/1.5 mg ... methylbromide oral solution (syrup), 5 mg/1.5 mg per 5 mL ... and children 6 years of age and older. Annual sales ... million.   ...
Breaking Medicine Technology: